Previous close | 8.82 |
Open | 8.85 |
Bid | 8.98 x 200 |
Ask | 9.03 x 200 |
Day's range | 8.79 - 9.02 |
52-week range | 8.21 - 12.03 |
Volume | |
Avg. volume | 366,513 |
Market cap | 433.964M |
Beta (5Y monthly) | 0.37 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.00 |
Earnings date | 06 May 2024 - 10 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 14.00 |
Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript February 26, 2024 Theravance Biopharma, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.04. TBPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, good afternoon. I’d […]
Theravance's (TBPH) fourth-quarter earnings and revenues beat estimates. The company achieves profitability on an adjusted basis during the same time. Stock rises.